Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

BACKGROUND: Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Tünnerhoff, Johannes, Mengel, Annerose, Kuhn, Joachim, Ziemann, Ulf, Poli, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919064/
https://www.ncbi.nlm.nih.gov/pubmed/33641678
http://dx.doi.org/10.1186/s42466-021-00105-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919064/
https://www.ncbi.nlm.nih.gov/pubmed/33641678
http://dx.doi.org/10.1186/s42466-021-00105-4

Ejemplares similares